Symbols

GTBP

GT Biopharma·NASDAQ

--(--)

7.59 / 10

Outperform

Analyst coverage is absent, but fund‑flow sentiment is strong at 7.59, indicating good liquidity. Inflow ratios around 45‑48% are present, yet trends are negative across all investor sizes, hinting at potential outflows.

Fund Flow Rating

Is money flowing into or out of GTBP?

GTBP holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.59/10 (Outperform).